During the last session, Medifast Inc (NYSE:MED)’s traded shares were 0.3 million, with the beta value of the company hitting 1.18. At the end of the trading day, the stock’s price was $19.53, reflecting an intraday loss of -1.11% or -$0.22. The 52-week high for the MED share is $96.01, that puts it down -391.6 from that peak though still a striking 8.55% gain since the share price plummeted to a 52-week low of $17.86. The company’s market capitalization is $213.66M, and the average intraday trading volume over the past 10 days was 0.41 million shares, and the average trade volume was 550.30K shares over the past three months.
Medifast Inc (MED) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3.50. MED has a Sell rating from 1 analyst(s) out of 3 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Medifast Inc (NYSE:MED) trade information
Medifast Inc (MED) registered a -1.11% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.11% in intraday trading to $19.53, hitting a weekly high. The stock’s 5-day price performance is -9.04%, and it has moved by 1.77% in 30 days. Based on these gigs, the overall price performance for the year is -78.94%. The short interest in Medifast Inc (NYSE:MED) is 2.96 million shares and it means that shorts have 4.0 day(s) to cover.
The consensus price target of analysts on Wall Street is $83.75, which implies an increase of 76.68% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $17.5 and $150 respectively. As a result, MED is trading at a discount of -668.05% off the target high and 10.39% off the low.
Medifast Inc (MED) estimates and forecasts
Statistics show that Medifast Inc has underperformed its competitors in share price, compared to the industry in which it operates. Medifast Inc (MED) shares have gone down -64.28% during the last six months, with a year-to-date growth rate less than the industry average at -88.28% against 11.20. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -113.20% this quarter and then drop -134.50% in the quarter after that. In the rating firms’ projections, revenue will decrease -43.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 134.15M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 129.95M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 235.87M and 191.01M respectively. In this case, analysts expect current quarter sales to shrink by -43.10% and then drop by -32.00% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 14.53%. While earnings are projected to return -88.43% in 2024, the next five years will return 20.00% per annum.
MED Dividends
Medifast Inc is due to release its next quarterly earnings 2024-Nov-04. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Medifast Inc is 1.65, with the dividend yield indicating at 8.45 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 5.39%.
Medifast Inc (NYSE:MED)’s Major holders
Medifast Inc insiders own 2.54% of total outstanding shares while institutional holders control 108.80%, with the float percentage being 111.64%. BLACKROCK INC. is the largest shareholder of the company, while 246.0 institutions own stock in it. As of 2024-03-31, the company held over 1.75 million shares (or 16.0962% of all shares), a total value of $67.13 million in shares.
The next largest institutional holding, with 1.26 million shares, is of PACER ADVISORS, INC.’s that is approximately 11.5443% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $48.26 million.
Also, the Mutual Funds coming in first place with the largest holdings of Medifast Inc (MED) shares are Pacer Small Cap U.S. Cash Cows 100 ETF and Invesco Global Opportunities Fund . Data provided on Apr 30, 2024 indicates that Pacer Small Cap U.S. Cash Cows 100 ETF owns about 1.33 shares. This amounts to just over 12.18 percent of the company’s overall shares, with a $26.03 million market value. The same data shows that the other fund manager holds slightly less at 396.99, or about 3.63% of the stock, which is worth about $7.75 million.
